Prescription drug · NDA
Triesence (Triamcinolone acetonide) NDC 82667-800
Triamcinolone acetonide 40 mg/mL · Injection, Suspension · Ophthalmic · Harrow Eye, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82667-800-01 | 8266708000182667080001 | 1 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASSMarketed from Oct 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Triesence
- Generic name (nonproprietary)
- triamcinolone acetonide
- Active ingredients
- Triamcinolone acetonide — 40 mg/mL
- Dosage form
- Injection, Suspension
- Route
- Ophthalmic
- Labeler
- Harrow Eye, LLCNDC labeler code 82667
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022048
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 82667-800_5386eec5-c123-04b8-e063-6294a90a2952SPL ID 5386eec5-c123-04b8-e063-6294a90a2952SPL set ID 2267978c-72ad-9229-e063-6394a90a09d0RxCUI 1086259, 1792144UNII F446C597KA
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482667080001followed by a unit qualifier and the quantityPackage 82667-0800-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
TRIESENCE suspension is a synthetic corticosteroid indicated for: • Treatment of the following ophthalmic diseases: sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. ( 1.1 ) • Visualization during vitrectomy. ( 1.2 ) 1.1 Ophthalmic Diseases TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL is indicated for: • sympathetic ophthalmia, • temporal arteritis, • uveitis, and • ocular inflammatory conditions unresponsive to topical corticosteroids. 1.2 Visualization During Vitrectomy TRIESENCE suspension is indicated for visualization during vitrectomy.
Excerpt only. Read the full label for complete information.
About NDC 82667-800
- What is NDC 82667-800?
- 82667-800 is the product NDC for Triesence (triamcinolone acetonide), Triamcinolone acetonide 40 mg/mL injection, suspension, listed with the FDA by Harrow Eye, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Triesence (Triamcinolone acetonide).
- What is the active ingredient?
- Triamcinolone acetonide.
- Who is the labeler?
- Harrow Eye, LLC, NDC labeler code 82667. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Triesence?
- 1 other product NDC are listed under this name. See all Triesence NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Triesence products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Triesencetriamcinolone acetonide | Triamcinolone acetonide 40 mg/mL | Injection, SuspensionOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0897 | 00078-0897-78 |
Other NDCs under NDA 022048
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Triesencetriamcinolone acetonide | Triamcinolone acetonide 40 mg/mL | Injection, SuspensionOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0897 |